Since HIF-1α appeared to be essential for BRG1 recruitment to the TWIST promoter, we asked whether HIF-1α inhibition would be sufficient to block EndMT and liver fibrosis. The gene discussed is SMARCA4; the disease is Hepatic fibrosis.